RESEARCH AND DEVELOPMENT AGREEMENTResearch and Development Agreement • August 16th, 2006 • Nuway Medical Inc • Retail-auto dealers & gasoline stations • California
This Research and Development Agreement (this “Agreement”) is made and entered into as of the 11th day of August, 2006 by and among BioLargo Life Technologies, Inc., a corporation organized under the laws of the State of California, having its principal offices at 2603 Main Street, Suite 1155, Irvine, California 92614(“BLTI”), NuWay Medical, Inc., a corporation organized under the laws of the State of Delaware, having its principal offices at 2603 Main Street, Suite 1155, Irvine, California 92614 (“NuWay”), IOWC Technologies Inc., a corporation organized under the laws of Canada, having its principal address for service at 17731-103 Avenue, Edmonton AB T5S 1N8 (“IOWC”) and Kenneth R. Code, whose address is #4, 1780 Glastonbury Boulevard N.W., Edmonton, Alberta TST 6P9 (“Code”). BLTI, IOWC, NuWay and Code are sometimes referred to herein collectively as the “Parties” and individually as a “Party”.
AMENDMENT NO. 1Research and Development Agreement • August 16th, 2006 • Nuway Medical Inc • Retail-auto dealers & gasoline stations
This Amendment Number 1 to Research and Development Agreement (this “Amendment No. 1”) is made and entered into effective as of this 14th day of August, 2006 by and among NuWay Medical, Inc., BioLargo Life Technologies, Inc, IOWC Technologies, Inc. and Kenneth Reay Code. Capitalized terms used herein without definitions shall have the same meanings as defined in the Research and Development Agreement by and among the parties hereto dated August 11, 2006 (the “R&D Agreement”)
